本页面由Tiger Trade Technology Pte. Ltd.提供服务

OncoCyte Corporation

3.20
0.0000
成交量:- -
成交额:31.84万
市值:9,151.77万
市盈率:-0.96
高:3.20
开:3.20
低:3.20
收:3.20
52周最高:4.75
52周最低:1.92
股本:2,859.93万
流通股本:775.50万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.3429
每股收益(LYR):-4.6612
净资产收益率:-428.96%
总资产收益率:-22.17%
市净率:8.96
市盈率(LYR):-0.69

数据加载中...

2019/08/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/07/26

持股变动声明

Initial statement of beneficial ownership of securities
2019/07/23

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/07/23

重要事件披露

Current report, items 5.02, 5.07, and 9.01
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/08

重要事件披露

Current report, items 5.02 and 9.01
2019/07/05

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/05

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/03

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/17

SEC问询函

[Cover]Correspondence
2019/06/06

重要事件披露

Current report, items 5.02, 5.08, and 9.01
2019/06/03

持股变动声明

Initial statement of beneficial ownership of securities
2019/05/14

重要事件披露

Current report, items 2.02 and 9.01
2019/05/14

季度报告

Quarterly report [Sections 13 or 15(d)]